Clinical Trials Directory

Trials / Sponsors / HighTide Biopharma Pty Ltd

HighTide Biopharma Pty Ltd

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
CompletedEffects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequa
T2DM (Type 2 Diabetes Mellitus)
Phase 32024-06-04
CompletedEfficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Cont
Type 2 Diabetes Mellitus
Phase 32023-11-13
CompletedEfficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes
T2DM (Type 2 Diabetes Mellitus)
Phase 32023-11-05
CompletedHTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabete
Nonalcoholic Steatohepatitis (NASH), Type 2 Diabetes
Phase 22022-12-27
CompletedA Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controll
Type 2 Diabetes Mellitus
Phase 22022-03-31
CompletedOpen-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis
Primary Biliary Cholangitis, Primary Biliary Cirrhosis, Cholangitis
Phase 22021-05-27
WithdrawnA Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)
Primary Sclerosing Cholangitis, Cholangitis, Cholangitis, Sclerosing
Phase 22021-03-01
CompletedA Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)
Fatty Liver, Nonalcoholic, NAFLD, Nonalcoholic Fatty Liver Disease
Phase 22018-11-26
CompletedA Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia
Hypercholesterolemia
Phase 1 / Phase 22018-04-13
CompletedA POC and Dose-Ranging Study of HTD1801 in PSC Patients
Primary Sclerosing Cholangitis (PSC)
Phase 22018-02-09
CompletedA Study of HTD1801 in Healthy Subjects
Primary Sclerosing Cholangitis
Phase 12017-03-24
CompletedStudy of HTD4010 in Healthy Volunteers
Type 2 Diabetes Mellitus
Phase 12015-10-01